Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
RecruitingNCT07619989Phase: NAStarted 2026-04-21
Summary
This is a single-center, randomized, participant-blinded, sham-controlled pilot trial designed to evaluate the adjunctive effect of transcutaneous auricular vagus nerve stimulation (taVNS) in overweig
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
50 Years
Locations
Department of Endocrinology, the Affiliated Drum Tower HospiNanjing, Jiangsu, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07619989